The "new genetics" and clinical practice

Medical Journal of Australia

Volumn 178, Issue 8, 2003, Pages 406-409

  Trent, Ronald J A ^a,b   Williamson, Robert ^c   Sutherland, G R ^d  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; DNA SCREENING; FAMILY; GENE TECHNOLOGY; GENERAL PRACTITIONER; GENETIC ANALYSIS; GENETIC COUNSELING; GENETICS; GENOME; HEALTH PRACTITIONER; HUMAN; MEDICAL SPECIALIST; PATIENT; PHYSICIAN ATTITUDE; PREDICTION; PRENATAL DIAGNOSIS; SHORT SURVEY;

EID: 0037623524     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05262.x     Document Type: Short Survey

References (9)

1. Apolipoprotein E; APOE. MIM Number 107741. Online Mendelian Inheritance in Man (OMIM). Baltimore MD: Johns Hopkins University. Last edited 6 Sep 2002. Available at: http://www.ncbi.nlm.nih.gov/omim/ (accessed Mar 2003).
2. Powell LW. Hereditary hemochromatosis and iron overload diseases. J Gastroenterol Hepatol 2002; 17: S191-S195.
3. Robson KJH, Merryweather-Clarke AT, Pointon JJ, et al. Diagnosis and management of haemochromatosis since the discovery of the HFE gene: A European experience. Br J Haematol 2000; 108: 31-39.
4. Culver JO, Hull JL, Levy-Lahad E, et al. BRCA1 and BRCA2 hereditary breast/ovarian cancer. Updated 4 March 2000. In: GeneReviews at GeneTests. GeneClinics: Medical Genetics Information Resource (database online). Seattle: University of Washington, 1997-2002. Available at: http://www.geneclinics.org (accessed Dec 2002)
5. Goizet C, Lesca G, Durr A. Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias. Neurology 2002; 59: 1330-1336.
6. Lloyd FJ, Reyna VF, Whalen P. Accuracy and ambiguity in counseling patients about genetic risk. Arch Intern Med 2001; 161: 2411-2413.
7. Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med 2002; 126: 1304-1318.
8. Yapp TR, Eijkelkamp EJ, Powell LW. Population screening for HFE-associated haemochromatosis: Should we have to pay for our genes? Intern Med J 2001; 31: 48-52.
9. Harris MF. Case conferences in general practice: Time for a rethink? Med J Aust 2002; 177: 93-94.